Brain development in a dish by Pronk, Robin Johan
From THE DEPARTMENT OF NEUROSCIENCE 
Karolinska Institutet, Stockholm, Sweden 
BRAIN DEVELOPMENT IN A DISH 
Robin Johan Pronk 
 
Stockholm 2020 
 
 Cover: “Tying together the brain and a dish” by Robin Johan Pronk 
Illustrations were made using Sevier Medical Art (smart.servier.com) 
All previously published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet. 
Printed by Universitetsservice US-AB 2020 
© Robin Johan Pronk, 2020 
ISBN 978-91-7831-770-7  
  
Brain Development In A Dish 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
By 
Robin Johan Pronk 
 
 
Public defense:  
 
 
 
Friday 27th of March 2020  
Lecture hall: Biomedicum 1, 09:30 
Solnavägen 9 
 
 
Principal Supervisor: 
Associate Professor Anna Falk 
Karolinska Institutet 
Department of Neuroscience 
 
Co-supervisors: 
Associate Professor Eva Hedlund 
Karolinska Institutet 
Department of Neuroscience 
 
Professor Klas Blomgren 
Karolinska Institutet 
Department of Woman’s and 
Children’s’ Health 
 
Chair 
Dr. Jonathan Coquet 
Karolinska Institutet 
Department of Microbiology, 
Tumor and Cell Biology 
 
Opponent: 
Professor Ana Martin-Villalba 
German Cancer Research Center 
Division of Molecular Neurobiology 
 
Examination Board: 
Associate Professor Gonçalo Castelo-Branco 
Karolinska Institutet 
Department of Medical Biochemistry and 
Biophysics 
Division of Molecular Neurobiology 
 
Professor Mattias Alenius 
Umeå Universitet 
Department of Molecular Biology 
 
Dr. Elisabet Andersson 
Karolinska Institutet 
Department of Comparative Medicine 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Essentially, all models are wrong, but some are useful” 
George E.P. Box

  
ABSTRACT 
This thesis shows the path I took in the quest for modeling the brain, as the title 
says, in a dish. The introduction of induced pluripotent stem cells (iPSCs) as means 
to research biological processes has opened up whole new fields of study and 
unprecedented possibilities of generating human cells in vitro. iPSCs have due to 
their pluripotent state the theoretical ability to be an unlimited source of cells, 
capable to generate any cell of the human body. They can be derived from somatic 
tissue and therefore used to generate disease specific cells. In paper I, we show 
the generation of disease specific neural stem cells from lissencephaly patients 
carrying a mutation in doublecortin (DCX). Lissencephaly is a disorder that affects 
cell migration, a phenotype we could replicate in our model. Furthermore, we show 
a defect in proper neurite outgrowth that we could rescue through the SLIT/ROBO 
pathway, and a prolonged proliferation. Together, showing the feasibility of using 
iPSC derived neural stem cells to model human neurodevelopmental disorders 
such as lissencephaly. In paper II we explored the role of p53 in neurodevelopment 
using both iPSC derived neuroepithelial stem cells (NES) and 3D brain organoids. 
Here we used lentiviral knockdown of tumor protein (TP53) in both the NES and 
iPSCs to follow neural development. We show the importance of p53 in maintaining 
genomic stability of NES cells and the involvement in maintaining the metabolic 
balance, resulting in lower expression of oxidative phosphorylation (OXPHOS) 
genes, shifting the cells to a more glycolytic state. Further differentiation into 
neurons showed an increased pace of differentiating. When placing p53 in the 
context of brain organoids, we show the reduction of TBR2+ intermediate 
progenitor cells  (IPCs) and TBR1+ neurons. Analyzing metabolic gene profile  also 
revealed the downregulation of OXPHOS related genes, indicating the regulation 
by p53 of the metabolism in brain organoids. In the manuscript, we explored a 
more metrological aspect for modeling neurodevelopmental diseases. By 
generating brain organoids and evaluating the neuronal activity we show the 
feasibility for future drug screening. Furthermore, we could perform an in vitro 
transplantation of NES cells and show their differentiation, making a small step 
towards an alternative for in vivo transplantation.  
In summary, this thesis shows some of the potential of in vitro brain development 
and the applications these brain models can be used for. 
  
NEDERLANDSE SAMENVATTING 
Dit proefschrift toont het pad dat ik heb gevolgd in de zoektocht naar het 
nabootsen van de hersenen, zoals de titel al luid, in een schaal. De introductie van 
geïnduceerde pluripotente stamcellen (iPSC's) als middel om biologische 
processen te onderzoeken, heeft volstrekt nieuwe onderzoeksgebieden en 
ongekende mogelijkheden voor het genereren van menselijke cellen in vitro 
geopend. iPSC's hebben vanwege hun pluripotentie het theoretische vermogen 
om een onbeperkte bron van cellen te zijn, in staat om elke cel van het menselijk 
lichaam te genereren. Ze kunnen worden gemaakt van somatisch weefsel en 
daarom worden gebruikt om ziekte specifieke cellen te genereren. In artikel I laten 
we de generatie van ziekte specifieke neurale stamcellen zien van lissencefalie 
patiënten met een mutatie in het doublecortin (DCX) gen. Lissencefalie is een 
aandoening die celmigratie beïnvloedt, een fenotype dat we in ons model kunnen 
repliceren. Bovendien tonen we een defect in de uitgroei van neurieten aan die we 
via het SLIT / ROBO-pad kunnen redden. Samengenomen tonen we de 
haalbaarheid van het gebruik van van iPSC afgeleide neurale stamcellen om 
menselijke neurologische ontwikkelingsstoornissen zoals lissencefalie te 
modelleren. In artikel II hebben we de rol van p53 in de neurologische ontwikkeling 
onderzocht met behulp van iPSC-afgeleide neuroepitheliale stamcellen (NES) en 
3D-hersenorganoïden. Hier hebben we lentivirale knockdown van tumor-eiwit 
(TP53) gebruikt in zowel de NES als iPSCs om de neurale ontwikkeling te volgen. 
We tonen het belang van p53 aan bij het handhaven van de genomische stabiliteit 
van NES-cellen en de betrokkenheid bij het handhaven van de metabolische 
balans, resulterend in een lagere expressie van oxidatieve fosforylatie (OXPHOS) 
genen, waardoor de cellen meer naar een meer glycolytische toestand worden 
verplaatst. Verdere differentiatie in neuronen toonde een verhoogd tempo van 
differentiatie. Wanneer we p53 in de context van hersenorganoïden plaatsen, 
tonen we de reductie van TBR2+ intermediaire voorlopercellen (IPC's) en TBR1+ 
neuronen aan. Analyse van het metabole genprofiel onthulde ook de reductie van 
OXPHOS-gerelateerde genen expressie, hetgeen duidt op de regulatie door van 
het metabolisme in hersenorganoïden door p53. In het manuscript hebben we een 
meer metrologisch aspect onderzocht voor het modelleren van neurologische 
aandoeningen. Door hersenorganoïden te genereren en de neuronale activiteit te 
evalueren, toonden we de haalbaarheid aan voor toekomstige screening van 
geneesmiddelen. Verder slaagden we in het uitvoeren van een in vitro 
transplantatie van NES-cellen en konden we tevens hun differentiatie laten zien, 
waarmee we een stap zetten naar een alternatief voor in vivo transplantatie. 
  
Samenvattend, toont dit proefschrift een deel van het potentieel van in vitro 
hersenontwikkeling aan en de toepassingen waarvoor deze hersenmodellen 
kunnen worden gebruikt. 
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1 GENERAL INTRODUCTION 
The 20th century was the starting point for “Modern Neuroscience”. Most famously, 
Camillo Golgi (July 7th, 1843 – January 21st, 1926) and Santiago Ramón y Cajal (May 
1st 1852 – October 17th 1934). The two inspiring scientists had opposing views on 
how neurons formed a network, but were both awarded the Nobel Prize in 
Physiology or Medicine (1906). Golgi developed the “Black Reaction” (nowadays 
known as the Golgi stain) 1, in which only a few percent of neurons are labeled 
entirely black. To date, it is not known why only a subset of cells are stained or, why 
particularly those cells are stained 2. Panel 1 in Figure 1 shows a drawing made by 
Golgi, displaying cell types in the human cerebral cortex 1,3. Panel 2 shows a 
photomicrograph of a pyramidal neuron in the cerebral cortex. One can appreciate 
the similarities between the drawing and the photograph, made over 100 years 
later.  
 
 
Figure 1: Panel 1: Golgi’s drawing of the cell types of the human cerebral cortex. Golgi divided 
the cortex into three laminae: a superficial layer with small pyramidal cells; a middle layer with 
larger pyramidal cells; and a deep layer with fusiform cells. Reproduced with permission from the 
publisher from Glickstein 2006, original drawing from Golgi 1885.      
Panel 2: Left panel: Photomicrograph of a fifth-layer pyramidal neuron in the motor cortex. 
Arrows show the apical and basal dendritic branchlets from where the spines were counted. Scale 
bar = 150 μm. Right panel: Photomicrographs of the thin (t), mushroom (m), stubby (s), wide (w), 
and branched (b) spines (arrows); as those counted in this study. Scale bar = 2 μm. Reproduced 
with permission from the publisher from Vazquez-Herna ndez et al., 2017. 
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It was with the staining technique from Golgi that Cajal contributed to the growing 
theory that neurons were not physically joined together (The Neuron Theory) and 
thus did not form a continuous network (The Reticular Theory). Therefore, Cajal 
established further the concept that neurons are individual units, part of a bigger 
network. The irony of it all is reflected in Cajal’s comment of shared Nobel Prize:” 
What a cruel irony of fate of pair, like Siamese twins united by the shoulders, 
scientific adversaries of such contrasting character!”. Golgi and Cajal had similar 
methods, but came to a fundamental different hypotheses in their understanding 
of the nervous system. In the same year as Golgi and Cajal were awarded the Nobel 
Prize, Sherrington laid the groundwork of an information transfer system between 
neurons (first published in 1906 4). It was not until 50 years later, with the use of the 
electron microscope, that the unequivocal existence of the synapse, and thus the 
view of neurons as individual units was published 5,6.  
 
With that in mind, I like to reflect that, the methods of today dictate the theories, 
but the future holds the answer. 
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1.1 BRAIN DEVELOPMENT 
There are countless cell types in the brain, each with their own regional 
specification, generated in a timely manner (Neurogenesis followed by 
Gliogenesis) and guided to their place by a plethora of signaling factors and 
pathways. Once these cells find their way (Migration), climbing under, over, and 
sideways along other cells, they arrive at their destination. Presumably the 
environment informing them, this is home, settle in, it was a long journey. After 
they are settled, the social butterflies they are, they want to meet and connect with 
many more similarly minded cells. With a process that includes more and more 
dendrites and axonal projections to travel to potential new friends, guided by 
factors to attract and repulse (Neurite outgrowth). Every time they find a fellow 
likeminded cell, they will connect, forming a synapse allowing them to 
communicate (Neural signaling). When you keep in touch with your friends, this 
connection grows in strength over time, and dwindles when neglected. Therefore, 
constantly shaping the brain and its connections as it seems fit through 
development and continuing well into the 3th decade of life. 
Now in this brief overview of brain development there are several topics in relation 
to this thesis that I will discuss in the following chapters      
  
1.2 FROM NEURAL STEM CELLS TO THE BRAIN  
 
 
Figure 2: General overview of human brain development, adapted with permission from the 
publisher, Bhaduri et al., 2020 
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1.2.1 Neuroepithelial stem cells 
Neuroepithelial stem cells (NES) form the foundation on which the brain is built. 
They show a polarized apical-basal organization, with adherence as well as tight 
junctions at the apical end of the cell maintaining polarity and organization 7-11 (The 
side lining the ventricle). This layer of cells looks pseudostratified, due to the 
interkinetic nuclear movement (IKNM) of the nuclei 7,8,12-14. When observed in 
sections, the cells are still one layer, but have their nuclei on different levels. The 
IKNM corresponds to a specific phase in cell cycle 15,16. After advancing through the 
cell cycle, NES cells divide either symmetrically, or a-symmetrically. This leads to 
first the lateral expansion of the neo-cortex by symmetrical division 17, and second 
to an a-symmetrical division that yields a daughter NES cell and the first group of 
neurons 18,19. Besides symmetrical division and generation of more NES cells, these 
stem cells later turn into radial glia cells.    
 
1.2.2 Radial Glia 
Radial Glia (RG) cells, first identified as scaffold for migrating neurons 20,21 share 
many features with NES cells, and were therefore difficult to distinguish. RG as well 
as NES cells, contact both the ventricular and pial surface of the developing brain, 
and exhibit IKNM 22. However, while in the NES cells this movement is across the 
entire cell, RG nuclei only migrate across the span of the ventricular zone. Overlap 
in the expression of NESTIN 23,24, marks them as well as stem cells, and the 
extension of a cilium contacting the cerebrospinal fluid in both NES cells and RG 
cells 25,26, further established their similarities. The transition from NES cells to RG 
cells comes with astroglial features. Glial fibrillary acidic protein (GFAP) is 
expressed in astrocytes and primate radial glia 20, where the delta isoform of GFAP 
is specific to the sub-ventricular zone (SVZ) in humans 27 but not in mice 28. Brain 
lipid-binding protein (BLBP) 29,30 and glutamate aspartate transporter (GLAST) 31 are 
more specific to radial glia in development, while in later developmental stages 
these markers become restricted to astrocytes. Besides just acting as a scaffold as 
originally thought 20,21, RG cells serve as main neurogenic centers in the developing 
cortex 32-34. The potential of RG cells is thus far described as multi-potent. At early 
stages, RG cell divide to expand their progenitor pool, while at later stages a-
symmetric divisions generating a RG cell and an intermediate progenitor (IP) cell 
become more standard 35,36. IPs line an area adjacent to the ventricular zone in the 
developing cortex and are marked by SVET1 and TBR2 expression 37,38. Later in 
human development, the progenitor pool expands with radial glia types such as, 
ventricular RG (vRG), truncated RG (tRG), 39 and outer RG (oRG) 40 populating the 
inner- and outer-subventricular zone (iSVZ and oSVZ, respectively). With the finding 
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that a singular oRG cells can produce hundreds of deep and upper cortical layer 
neurons, it is thought that these cells are significant contributors to the enlarged 
oSVZ seen in humans 41. The generated neurons have to migrate away from this 
niche to their respective place in the cortex. During neurogenesis in the cortex, the 
layers are generated in an “inside out” manner 42,43, meaning the newest neurons 
have to migrate past existing ones.  
 
1.2.3 Migration  
During the early neurogenic period, NES cells divide a-symmetrically, giving rise to 
an equally potent daughter stem cell and a neuron 44,45. For this neuron to reach its 
destination it will migrate from the apical surface to the basal surface. As observed 
in the fetal monkey cortex, migrating neurons are in close proximity to RG fibers, 
which act as support and guidance for migrating neurons 46. By live cell imaging it 
can be observed that newborn cortical neurons migrate by forming a leading edge 
that is protruded from the neuron, followed by soma translocation 47. It is evident 
that the movement of cells in general requires plenty of structural changes to the 
cell’s cytoskeleton. A major component of the cytoskeleton are microtubules which 
regulate and facilitate polarity and direction of migrating neurons 48,49, as well as 
coupling of the leading edge to the movement of the nucleus 50. Microtubules 
themselves consist of alpha- and beta-subunits connected to form long tubes, 
stabilized by microtubule associated proteins, one of which is doublecortin (DCX). 
This protein is stabilizing microtubules in migrating and differentiating neurons as 
their growth cones are pathfinding and the cell is dragged along its chosen path 
51,52.  
 
1.2.3.1 Lissencephaly – A Neuronal Migration Disorder 
When newborn neurons fail to reach their respective destination, they settle 
randomly, resulting in a disorder called lissencephaly 53,54 (“smooth brain”, from the 
Greek “lissos”, smooth and, “enkephalos”, brain). Normally neatly organized in six 
separate layers, the cortex of patients suffering from lissencephaly often present 
with only fewer distinct layers and with diminished to absent gyrification. 
Lissencephaly can be caused by mutations in several genes such as: PAFAH1B1 
(LIS1), ARX, RELN, VLDLR, TUBA1A, and DCX (as listed previously 55 and shown in 
Figure 3). 
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Of these, PAFAH1B1 (LIS1) and DCX mutations account for roughly 76% of classical 
lissencephaly cases 56. Described as a classical neural migration disorder 57, DCX 
dependent lissencephaly is an X-linked disorder 58. DCX is expressed in migrating 
neurons of the human brain 59 and regulates the stability and organization of 
microtubules 52,59,60. In females, due to the random X-inactivation in development, 
two populations of migration neurons are formed. One population with WT DCX 
form and function, and another population with less or non-functional DCX, leading 
to subcortical band heterotopia (SBH) 61. Therefore, the phenotype seen in males 
is more severe with substantially diminished or a lack of gyrification. Varying 
mutations in the DCX gene are associated with a heterogeneity of phenotypes 62,63. 
The DCX gene encodes for a brain specific, 360 amino acids long and a predicted 
40 kDa protein 57,58. Interestingly, the phenotypes in human are not replicated in a 
knockout (KO) mouse model 64. The authors show the lamination of the 
hippocampus is disrupted, however the layering of the cortex is unaltered. Later 
research hinted towards a compensatory mechanism in mice, that evidently is not-
existent or insufficient in humans 65,66. 
 
Figure 3: Schematic representation of the localization of different neuronal populations in the 
cerebral mantle of normal and lissencephalic brains, highlighting the differences of cortical 
lamination defects. CP cortical plate, IZ intermediate zone, E ependyma. Reproduced from Friocourt 
et al., 2010 67. With permission from the journal 
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1.2.4 Neurite outgrowth 
Whether it is some form of extension that grows out of a migrating neuron at its 
leading edge, or the extensions that later form the axons and dendrites in the brain, 
they rely heavily on microtubules and their stabilization 53,68. For the cell to decide 
the direction it needs to grow in, it needs some guidance. Chemo attractants and 
chemo repellents, like the name suggests, attract and repel neurons and neurites 
that are making their way through the brain. Several navigational mechanisms have 
been described 69, of which many have been found to be an attractant in one 
scenario and a repellent in another 70,71. Factors such as differential receptor 
activation 72 and different levels of intracellular second messengers 73 can aid in the 
switch from an attractant to repellant and vice versa. One of the navigational 
mechanism migration neurons and neurites use is the SLIT/ROBO pathway 74,75. 
Newly born neurons use this pathway to migrate through the glial meshwork 76 and 
a knockdown (KD) of SLIT 3 and added ROBO1/2 protein promotes neurite 
outgrowth in lissencephaly patients cells where impaired neurite outgrowth is 
observed 77.  
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1.3 P53 IN BRIEF 
The transcription factor p53 is most famous for its role as tumor suppressor, since 
the gene is mutated in approximately 50% of all human cancers 78. There is a strong 
positive correlation between larger animals and their lifespan 79.  Interestingly, TP53 
copy number expansion is associated with an increased body size during evolution 
79. The 20 copies of TP53 retrogenes that elephants carry and their enhanced DNA 
damage response 79,80 show a remarkable, albeit extreme difference in p53 within 
mammals. p53, famously known as guardian of the genome 81, made its appearance 
in literature in 1979 82,83. First thought to be an oncogene, undoubtedly because of 
its mutated form being present in so many cancers. Later work showed the wildtype 
(WT) variant to be one of the most important tumor suppressors known to date 84. 
Over the years a plethora of p53 functions have come to light. As summarized 
previously 85 (Figure 4), involvement of p53 has been shown in, but not limited to: 
Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage and response, 
Inflammation, Metabolism, Proliferation, Reactive oxygen species and, Stress 
response. 
                          
Figure 4: The p53 network. Kastenhuber and Lowe, 2017, reproduced with permission from the 
publisher. 
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1.3.1 P53 in development 
The first indication for the role of p53 in development were surprisingly mild, 
considering the array of functions it is involved in. The p53 KO mouse is reported 
to “develop normally”, but is vulnerable to tumor development 86. In humans, it is 
known that a mono-allelic mutation of TP53 leads to Li-Fraumeni syndrome. Here, 
affected individuals carry heterozygous germline mutations in the TP53 gene. 
These individuals usually develop cancers during their lifetime 87,88 and even with 
the exclusion of more sex-specific cancers (breast, ovarian, and prostate cancer), 
the incidence is still higher in females than in males 89,90. The heavier burden in 
females is especially present when observing p53 KO mice. Not only are female 
mice underrepresented 91, a subset of female mice develop exencephaly following 
neural tube closure defects (NTDs), whereas p53-/- males do not exhibit NTDs 91,92. 
The penetrance for NTDs in females varies between 17-60% depending on genetic 
background and the conducted study 91,92. Only recently, it has been shown that 
the NTDs are due to the binding of p53 to the X-chromosome inactivation center 
(XIC) and thereby promoting the stochastical inactivation of one of the female X-
chromosomes 93. The authors show, that in absence of p53 Xist expression is 
reduced, which leads to a subsequent diminished number of Xist clouds in a subset 
of cells, suggesting the direct activation of XIC genes by p53. Without p53 some 
cells are not able to repress XIC genes and therefore cause NTDs. 
1.4 METABOLISM 
Talking about the metabolism of a cell, we mainly refer to two energy producing 
pathways: Glycolysis and Oxidative phosphorylation (OXPHOS). It has been shown 
that during the development from a neural stem cell to a neuron, the progenitor 
cell relies more on glycolysis, whereas the neurons rely on OXPHOS 94,95. The 
developing embryo is almost exclusively glycolytic throughout the neural tube, 
neural crest, and brain vesicle development 96. In terms of net energy production, 
glycolysis is relatively inefficient with two ATPs (anaerobic glycolysis) or four ATPs 
generated (aerobic glycolysis) versus OXPHOS with 36 ATPs. OXPHOS and 
glycolysis are not mutually exclusive processes, a particular cell can possibly utilize 
both pathways. Interestingly, recent findings point towards a metabolic 
collaboration between neurons, resident astrocytes, and oligodendrocytes, named 
the astrocyte-oligodendrocyte-neuron lactate shuttle (AONLSH) 97,98. One of the 
key components is, as the name suggests, the use of glycolysis (glucose is 
eventually metabolized to lactate via pyruvate) by astrocytes and oligodendrocytes 
as a source for interstitial lactate. This lactate is taken up by the neurons and used 
in the OXPHOS pathway, where lactate is converted to pyruvate, which is essential 
for the production of Acetyl-coA by the TCA cycle, which in turn produces NADH 
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for the electron transport chain and the OXPHOS generation of ATPs 99,100. The 
question is, to what extend the neurons can self-support their energy needs in the 
absence of astrocytes. Gliogenesis generally occurs only after all neuronal layers 
are formed, thus there is a significant period of astrocyte absence in early brain 
development. One of the hallmarks of differentiating neurons is the requirement 
of making a glycolysis to OXPHOS switch. Neural stem cells are mainly glycolytic 95 
and require a connection between aerobic glycolysis and OXPHOS for 
differentiation 101. Downregulation of glycolysis genes is essential for neuronal 
differentiation 95 and genetic inhibition of mitochondria (OXPHOS) impairs 
neurogenesis in vivo 102 thus indicating the need for balance and versatility of a 
proper metabolic energy profile. 
 
1.5 UNDERSTANDING NEUROPSYCHIATRIC DISORDERS 
Neuropsychiatric disorders might very well be one of the most difficult conditions 
to understand, considering the relative limited knowledge we have about the brain. 
In cases of autism spectrum disorder (ASD) and schizophrenia (SZ) some 
phenotypes like communication difficulties are shared with common genetic 
overlap 103,104 thus affecting the “Social brain” 105, that can be associated to 
prefrontal cortical development 106. As shown by valiant efforts of many 
laboratories, the complexity of these diseases is enormous. Genome Wide 
Association Studies (GWAS) have identified many different mutation hotspots and 
copy number variations (CNVs) 103,107,108, some CNVs with significant overlap 
between ASD and SZ 104. Efforts are towards recapitulating what is called the DSM-
V classification of in this case ASD and SZ. Diagnosis is made through thorough 
clinical evaluation in the case of ASD: Deficits in social-emotional reciprocity, 
nonverbal communication, developing and maintaining relationships and more. 
And for SZ: “delusions, hallucinations, diminished emotional expression and 
others”. For full DSM classification and explanation, see DSM-V 109. Research is 
constantly developing and the more we know about the brain and its functions the 
better we will become in replicating and possibly treating such intricate disorders. 
Like many research areas, new techniques uncover previous unknown cell types, 
cell states and functions, and the brain is no exception. Whether it is the recent 
classification of new neuronal and glial subclasses 110,111, or the classification of an 
entire new neuron 112, it shows the complexity that is the human brain and its 
functions, and the need for reliable models.  
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1.5.1 In Vivo – Human and Animal models 
From the seemingly impossible task of the datasets that GWAS analysis generates, 
target pathways and genes are found which can be applied to more specific 
research systems. Most commonly, the mouse brain is used as a model system. In 
the mouse models, gene expression can be altered and pathways can be inhibited. 
Subsequently, histological and functional review of the brain and its (higher) 
functions can be performed as reviewed for both SZ 113 and ASD 114. Methods such 
as transgenic animals, viral alteration of gene expression, pharmacological 
intervention of neurotransmitter function, environmental stress (during 
development or in adult), and electrical stimulations have been used as approaches 
to construct an animal model (as reviewed before 115). Arguably, the main upside 
and downside is that the work is done in a rodent. On one hand, there is an actual 
ability to test behavioral interactions, however done in an animal that in some ways 
differs in cellular composition and function from humans. As recently shown, 
differences between mouse and human or even chimpanzee and human are 
highlighted. For example, the regulation of cortical neurogenesis can differ 116, 
human specific genes 117,118, neurons 112 and even glial function 119-121. Despite all the 
differences, in the end, rodents still present a model that can lead to insights in the 
behavioral effects in a larger context. 
 
1.6 IN VITRO - CELLULAR MODELS 
Of course, the drawbacks of behavior analysis seen in animals, due to not being 
human, are almost insignificant compared to cells in a dish. However, with the 
discovery of reprogramming, a new avenue of human cells in a dish became 
feasible, without relying on immortalized cell lines derived from cancer patients.  
1.6.1 Induced Pluripotent Stem Cells 
The introduction of “reprogramming” cells to a undifferentiated state came first by 
Gurdon in 1962 122, with presenting somatic cell nuclear transfer. Here, the nucleus 
of a somatic cell is transferred to an enucleated oocyte. In this process the somatic 
nucleus is “reprogrammed” by the oocyte. Many years later, in 2006, a true 
revolution in human cell culture was discovered. Yamanaka found first in mice, and 
later in human 123,124 that the introduction of four factors (Oct4, Sox2, Klf4, and c-
Myc; OSKM factors) was enough to reprogram fibroblasts into pluripotent stem 
cells (PSCs) that resembled embryonic stem cells (ESCs). Just shortly after, 
Thompson’s lab showed a cocktail OCT4, SOX2, NANOG, and LIN28 was also 
sufficient to reprogram somatic cells 125. They termed these cells induced 
pluripotent stem cells (iPSCs). Realizing the potential of these iPSCs, the idea of 
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reprogramming was awarded the Nobel Prize in 2012, shared between Gurdon and 
Yamanaka. Ectopic expression of the reprogramming factors was initially mediated 
by retroviral transduction. Like lentiviral transduction, retroviral is an integrative 
method, to deliver genes into the host genome, and with that the possibility for 
malignant transformations 126. Since then, other, non-integrating strategies have 
been developed such as: Sendai viral vectors 127, proteins128 and mRNA 129. All have 
been used to induce pluripotency in somatic cells, generally using the same original 
OSKM factors or a combination thereof. Interestingly, Oct4 was first shown to be 
crucial for the reprogramming process 123,124,130. However a recent publication 
showed that Oct4 could be omitted and that the “SKM-cocktail” (Sox2, Klf-4 and 
c-Myc) a more faithful epigenetic reprogramming131. 
 
1.6.2 iPSCs to Neuroectoderm 
To mimic parts of the brain, cells of the neuronal lineage are needed. Thus, the 
next step from iPSCs will be the differentiation towards neural ectoderm. Early 
protocols used embryoid bodies (EBs) followed by plating down in fibroblast 
growth factor (FGF)-2 containing media and isolation of neural rosette like 
structures resembling the neural tube 132,133 to generate some form of neural stem 
cell. These cells have a broad differentiation potential and the ability to be 
transplanted and show integration in vivo132,133. With efforts to optimize the 
generation of neural cells, researches had focused on signaling patterns to guide 
the PSCs towards neuroectoderm. It is generally considered that the pathways 
involving FGF, bone morphogenic proteins (BMPs) and, WNT play determining 
factors in patterning stem cells towards neural ectoderm 134. BMPs play a particular 
important role, as it has been shown early on that disruption of this pathway leads 
to the induction of neuroectoderm 135,136. And it was  the blocking of this pathway 
that led to the generation of a protocol that creates neuroectodermal cells from 
PSCs with high efficiency 137. This “dual SMAD inhibition” protocol utilized the 
blocking functions of Noggin and small molecule SB431542 (SB). Noggin as 
inhibitor for BMPs and SB as inhibitor for the Lefty/Activin/TGFß pathways, 
together generating a more efficient route to capture NES cells without the need 
of an EB stage.  
1.6.3 NES cells 
As stated before, NES cells form the neuroepithelium from which the brain is built. 
Therefore, these cells are of special interest if one wants to mimic brain 
development. In culture NES cells respond to FGF and EGF signaling 132,138 and 
have been shown to be generated from ESCs 139 and later iPSCs 140 which can 
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functionally integrate upon transplantation and, resemble a cell type found in the 
early human brain 141. Since then, we and others have shown the usability of these 
cells in modeling neurodevelopmental disorders 77,142,143, increased recovery after 
stroke and spinal cord injury 144,145 and, certain cancers like medulloblastoma 146,147.  
Neural differentiation protocols were generally developed with pure neuronal, 
astrocytic or oligodendrocyte purposes, and generally were achieved. However, 
this homogeneity can be construed as drawback for modeling the complexities of 
the human brain. And the practical and ethical concerns of endogenous brain tissue 
make post mortem, or abortion derived tissue a less reliable, although more 
representative model. Thus, the search for alternative models continued. 
 
1.6.4  Brain Organoids a.k.a. “Mini Brains” 
To improve recapitulation of in vivo neurological development, scientists started to 
culture neural tissue on low-adhesive plates to force the cells to self-organize, 
generating neural tube-like structures. These structures include a small lumen and 
radial orientated cells, reminiscent of radial glia that produce different neuronal 
subtypes 148. Further tweaking of the protocol by excluding serum from the medium 
and quick aggregation, resulted in a serum-free culture of embryoid body-like 
aggregates-quick (SFEBq) 149. Adding a supportive structure such as matrigel, 
resulted in the ability to grow even more complex whole brain organoids. These 
organoids consist of a lumen, lined with radial glia cells that give rise to several 
distinct cortical layers, and are even able to recapitulate key phenotypes of 
microcephaly 150,151. Later, researchers have modified the existing protocol in order 
to generate less complex but more specific regional organoids (e.g. forebrain, 
midbrain and hypothalamic organoids) 152. The promise of each of these techniques 
is that they recapitulate neuronal (disease) development and give insight into the 
mechanisms of cerebral development in health and disease. Relying on the self-
organization of the system comes with a drawback, variability. However, further 
progress has been made to reduce variability 153.  Interestingly, when researches 
compared available datasets from different protocols, both directed and non-
directed differentiation, they found a relative similarity between cell clusters albeit 
a slightly different path to get there 154.   
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1.6.5 How to get to an organoid 
1.6.5.1 IPSCs 
Utilizing these relative complex protocols to their full potential comes with several 
hurdles that scientists have to overcome. Establishing a pluripotent cell culture is 
laborious and demanding. Finding the right starting cells is key for the success of 
any protocol. Variations in pluripotent stem cell (PSC) colonies will result in 
inconsistent and irreproducible results. Defined cell substrates, and defined 
medium has been around for roughly 15 years 155-158. This together with a 
standardized protocol for the generation and maintenance of PSCs will result in 
iPSCs that are more resistant to DNA damage 159 and will possibly yield a more 
homogeneous pluripotent stem cell population. One way of interpreting the 
homogeneity of the PSCs is the (protein) expression levels of the classical 
pluripotency markers OCT4, NANOG, and SOX2. These factors are the drivers of 
pluripotency and their expression is tightly regulated. Each factor needs to be 
present in a specific ratio to another in order to maintain pluripotency. Moreover, 
different levels are required for different lineages. For example, an increase in 
expression of Oct3/4 tilts the differentiation towards primitive endoderm and 
mesoderm 160,161. Similar rules apply for Nanog and Sox2. Nanog represses 
ectoderm formation whilst Sox2 represses mesoderm specification 162. This stresses 
the importance of the starting material being as homogeneous as possible 
regarding the expression of key transcription factors to reduce variability and 
increase reproducibility between experiments. Heterogeneity amongst PSCs will 
result in varying “levels of pluripotency”, and thus discrepancies in differentiation 
capability. Therefore, striving for a homogeneous population of PSCs will aid in 
reducing variability and increases consistency between experiments. 
 
1.6.5.2 Embryoid bodies 
Most of the 3D culture methods are initiated by generating cell aggregates named 
EBs. There are numerous ways to generate these EBs as described by Hiroshi 
Kurosawa 163. These include the use of bacterial-grade dishes, methylcellulose 
culture and the hanging drop technique. Although all are effective ways to 
generate EBs, the outcome of the EBs vary across techniques. Using bacterial-
grade dishes or any other dish coated with anti-adhesive material, results in 
variability regarding EB size and number of EBs generated. This is highly depended 
on the dissociation technique used to detach the PSCs. When PSCs are allowed to 
remain in clumps, there is no control over amount and size of these clumps, 
resulting in variability amongst size of the generated EBs. As micro-patterning 
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techniques have shown that the size 
of EBs influences differentiation 
potential 164,165, it is preferred to 
generate the right size of uniform 
EBs to better control the outcome. 
The hanging drop method seems to 
alleviate many of the problems of 
other techniques. With the addition 
of Rho-associated protein kinase 
(ROCK) inhibitor that allows PSCs to 
be dissociated into single cells 166, 
scientists are able to consistently 
reproduce uniform sized EBs 167. But 
it is laborious and ideally there 
needs to be a dedicated incubator 
to reduce the risk of falling down or 
merging of the drops. To date, the 
optimal method is to use a 96 low-
adhesive round bottom well plate. 
These plates ensure uniformity of 
shape and size across EB 
generations. With the ability to 
adjust cell number per well and thus 
control the number of cells in a 
sphere, combined with easy access 
to change the medium, yields in an 
easy system with uniform results. 
This is necessary for reliable 
recognition of the stage of 
differentiation of the EBs.  
 
 
 
 
 
 
Figure 5: Timeline of Recent In Vitro Methods of 
Neural Differentiation. Kelava and Lancaster 2016, 
reproduced with permission from the journal. 
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1.6.5.3 Neuroectoderm 
For the generation of any type of brain organoids, EBs need to be directed towards 
the ectodermal lineage. Luckily, when EBs are maintained in minimal medium 
(without serum) their “default programming” is to adopt a neural fate 168. Due to 
the self-organizing capability of stem cells cultured in EB like aggregates, this 
represents itself as a bright ectodermal ring around a darker center. This is a crucial 
step before advancement to the next step in obtaining a neural fate. When EBs fail 
to display such a distinct morphological cue, continuation is mute since they have 
failed to generate ectodermal tissue. To guide differentiation further towards a 
neural fate, several protocols can be followed, all depended on which outcome is 
needed. In the last years several protocols have been developed for the generation 
of distinct brain regions like forebrain, midbrain, or hypothalamic 152, 
hippocampal/choroid plexus 169, cortical 170, cerebellar 171, whole brain organoids 
150. For a concise overview and timeline see 172 and Figure 5. Neuroectodermal 
tissue undergoes massive expansion during development. In order for aggregates 
to sustain the rapid proliferation, the brain-organoid field took lessons from work 
in other 3D culturing fields, most importantly, the work performed in the laboratory 
of Hans Clevers. There, they found that a supportive matrix is imperative to aid in 
expansion and self-organization of tissue in vitro 173. Matrigel is a key factor in 
enabling the expansion of neural ectoderm. 
 
1.6.5.4 Mature minibrains 
As by now numerous publications have shown, the usability for organoids is 
seemingly endless. The identification of functionality in the organoids and the 
resemblance they have to human brain development, becomes more and more 
apparent. By combining dorsal and ventral organoids, researchers have created a 
model in which they could trace the ventral neurons migrating to their dorsal 
destinations 174,175. Not only the migration between different brain regions is 
essential for brain development, but also the integration and feasibility to form 
functional neuronal networks is the key to a functioning brain. It has been shown 
that organoids form light sensitive photoreceptors that alter their electrical activity 
upon light stimulation. This is indicative not only for the generation of inter 
organoid connectivity, but also for a functioning network 176, and therefore the 
possibilities to test connectivity functions. To further the field, some limitations 
needs to be addressed. Generally relying on self-organization without (too much) 
inhibitors to guide organoid formation, results in variability. It has been shown that 
different protocols result in similar cell types generated, however with distinct 
preference in differentiation pathways to get there 154. Furthermore, the lack of 
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generating all six cortical layers and the disappearing of the distinct progenitor 
layer over time are crucial factors to address 172. Possibly the lack of a vasculature 
system, depriving the inner cells of nutrients, is a fundamental step to overcome. 
Thus far that is on its way to being solved by co culture and transplantation to the 
mouse brain 177-179. It is needed to slightly alter the different protocols to generate 
the diversity of cells types of the brain. Researches have generated microglia 180, 
astrocytes 181-183 and, oligodendrocytes 184,185 inside organoids and it seems just a 
matter of time before the protocols are combined and resulting in the generation 
of more of the brains’ cell types in a proper timeframe. 
 
 
 
 

   19 
 
 
2 AIMS 
With this thesis the aim was to generate and use brain development models, find 
the limiting factors, and overcome them. To achieve this, we have utilized a 
combination of approaches ranging from 2D to 3D models. 
 
Roles each paper fulfilled: 
• Paper 1 – An in vitro model of lissencephaly: expanding the role of DCX 
during neurogenesis 
Using a classical neurodevelopmental disorder (lissencephaly) to test 
the feasibility of 2D NES cells to replicate certain aspects of this disorder. 
 
• Paper 2 – p53 controls genomic stability and temporal differentiation of 
human neural stem cells and affects neural organization in human brain 
organoids  
Combining the 2D NES cells and 3D organoids to affirm the role of p53 
in neurodevelopment and to explore a phenotype that does not translate 
from mouse to human. 
 
• Manuscript – Generation of a 2D and 3D System to Understand 
Neuropsychiatric Disorders 
Taking advantage of the in vivo likeness of 3D organoids and 
translating them to a format that would allow for efficent 2D screening 
possibilities, as well as 3D applications.  
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3 RESULTS AND DISCUSSION 
3.1 PAPER I – AN IN VITRO MODEL OF LISSENCEPHALY: EXPANDING THE 
ROLE OF DCX DURING NEUROGENESIS 
In this project we sought to generate a model system for what has been described 
as a typical human disorder, lissencephaly, also known as “Smooth brain disease”. 
When caused by mutations in DCX, smooth brain disease is characterized by the 
disorganized lamination of the neocortex in males and subcortical band 
heterotopia in females, as it is located on the X-chromosome 57,58. The 
disorganization of the cortical layers is not recapitulated in mice 64, and thus, with 
our access to patient material and ability to derive neural stem cells from these 
patients, we explored the feasibility of an in vitro model for lissencephaly.  
 
Lissencephaly is a disorder with a neural migration phenotype. Neural migration is 
plainly movement of a neural cell from one place to another, usually attracted and 
repulsed by chemo- attractants and -repellants signaling on a growth cone like 
structure situated on the end of a neurite 186,187. We have shown the reflection of 
this principle in our lissencephaly model system. We show that in patients with a 
DCX mutation the migration of newborn neurons is impaired and that the neurites 
of these neurons are shorter. Interestingly, we could rescue the shorter neurites not 
only by the KD of the chemorepellent SLIT3, but as well by adding the SLIT3 ligands 
ROBO1/2. When researchers generated iPSCs from lissencephaly patients 
harboring missense mutations in TUBA1A, coding for a tubulin protein present in 
neurons, they also found decreased neurite length 188. This shows the 
reproducibility of this phenotype in the same disorder with a different causative 
mutation across laboratories.  
 
During brain development, neural stem cells need to ultimately generate post-
mitotic neurons that migrate away from the stem cell niche and establish 
themselves in the correct place and integrate into the network of axons and 
dendrites. In our DCX model we lastly showed the prolonged proliferation of neural 
progenitor cells using a neural differentiation protocol. Again, this can be viewed 
as one of the classical hallmarks of lissencephaly, in which the cortex is significantly 
thicker 57,189. Presumably, due to the prolonged proliferation period we found and 
increased number of proliferation cells in the DCX patients. Recent analysis of our 
transcriptome data does reveal an overrepresentation of FABP7 and HES5. FABP7 
(BLBP) a radial glia marker in the CNS 29 and HES5 involved in the neurogenic to 
gliogenic switch 190. Both indicate an interesting line of investication that can be 
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followed up on. Either a more radial glia like profile or the generation of astrocytes 
that happens in the differentiation of DCX patient cells can be a new phenotype in 
DCX-lissencephaly patients.  
3.2 PAPER II – P53 CONTROLS GENOMIC STABILITY AND TEMPORAL 
DIFFERENTIATION OF HUMAN NEURAL STEM CELLS AND AFFECTS 
NEURAL ORGANIZATION IN HUMAN BRAIN ORGANOIDS 
Here we sought to establish a human in vitro model for brain development involving 
one specific gene: TP53. Uncovering the role of p53 in human brain development 
we came across a plethora of genes. A total of 2159 genes are deregulated in 
p53KD NES cells. We used cell lines derived from two healthy individuals, and KD 
p53 with the use of two different shRNAs targeting different parts of the p53 
transcript. We confirmed the “guardian of the genome” to be safeguarding 
chromosomal rearrangements and to be an inducer of apoptosis upon DNA 
damage in our neural stem cells. Interestingly the loss of p53 did not result in cells 
exiting the stem cell state, but rather primed the cells for differentiation. 
Surprisingly, upon the KD of p53 in human NES cells, we observed a slower 
proliferation rate of these neural stem cells. This is in contrast to observations from 
isolated cells from the p53 KO mouse brain 191-193, where more proliferation as 
measured by neurosphere assay, is observed. This might be due to several factors 
and it would be of great interest to study where the discrepancies arise from. One 
factor could be species-dependent. It has been shown that human and mouse only 
share 44% of the gene regulatory network. Moreover, 1000 genes in the p53 
network are differently regulated 194,195. Another variable to consider would be the 
developmental stage of the cells. In our study we used NES cells to show a reduced 
proliferation rate. NES cells are a cell type that represent a population of neural 
stem cells in the human brain that is present around gestational week 5-7 141. 
Several studies reporting enhanced proliferation used adult mouse SVZ 192,193, or 
cells isolated from the olfactory bulb 196. Contradictory, researches have isolated 
NPCs from E13,5 p53 KO mouse brains, and did not detect increased proliferation, 
or after a BrdU pulse in the E16 telencephalon 197. In summary, all research 
performed so far yielded different outcomes. This stresses the fact that not only 
the method but also the timing and the location in the brain are important variables 
to consider.  
 
It is not all different between mouse and human neurogenesis. The general notion 
of p53 safeguarding the stem cell state and that loss of p53 results in 
differentiation, is a phenotype that is partially recapitulated in the human NES cells. 
Although the NES cells do not leave their stem cell state upon loss of p53, when 
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they are allowed to differentiate by removal of growth factors, they form more 
mature neurons faster. This accelerated differentiation is also seen after radiation. 
The p53 KO dentate gyrus reveals an increased generation of neurons 198, as well 
as increased proportion of differentiation markers in isolated neurospheres 191,197. 
Furthermore, spanning this phenotype across cell types, the mesenchymal 
differentiation of p53 KO cells was only half the time of WT p53 cells 199. This 
indicates that the regulation of differentiation by p53 is conserved across species 
and observed in different cell types and systems. 
 
Across species, the regulation of certain metabolic processes also seems to be 
conserved. However, as reviewed previously 200, whether p53 promotes or inhibits 
OXPHOS, glycolysis and/or, the TCA cycle could be tissue dependent. As our 
results show, metabolism is one of the major affected pathways in the p53 KD NES 
cells. Downregulation of the OXPHOS cluster genes, verified by the 
downregulating of DECR1, resulted in a glycolytic shift with upregulation of HK2 in 
our NES cells. Furthermore, PSA-NCAM+ isolated cells from our 3D organoids 
showed a similar downregulation of OXPHOS genes phenotype. Therefore, it is 
clear that p53 is a key regulator in balancing the cells’ energy needs by regulation 
of the metabolic pathways.  
 
To reflect on in vitro neurogenesis in greater context, we used organoids to mimic 
brain development. Using a system that has a high degree of transcriptional and 
epigenetic similarities to human brain development 201,202, we showed the effect 
that KD of p53 has on brain development. Most strikingly, the disorganization in 
cortical formation. SOX2+ stem cells are found outside of supposedly neurogenic 
regions, accompanied by its supposed daughter cells, TUJ1+ neurons. Interestingly, 
disorganization of cortical regions was reported in 53BP1 (encoding a p53 binding 
partner) KO organoids 116. Further quantification of the stem cell niche revealed a 
decrease in both TBR2+ progenitors and TBR1+ neurons. With the conformation 
that p53 is still very much downregulated, it is unquestioned that this has a major 
role in the observed phenotype. Continued analysis of the stem cell niche, showed 
at first counterintuitive results. The expression of cell cycle marker Ki67 was 
unaffected. At the same time, we could not observe differences in Ccas3+ cells, 
which at this timepoint would possibly indicate that the defect in neurogenesis 
resulted from an earlier phenotype. However, when analyzing the cell cycle with 
EdU, we observed an accumulation of cells in G1phase at the expense of S-phase 
indicating a slower proliferation rate, quite possibly a contributing factor to the 
diminished progenitor and neural population.  
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Interestingly, metabolic regulation is shown to be key for neurogenesis. Not only 
in in vitro neurogenesis 95,203, but also in hippocampal neurogenesis 102. Inhibition of 
mitochondrial complex function results in a suppression of neurogenesis, 
specifically at the IPC level. in our two systems, p53 KD NES cells have reduced 
mitochondrial complex function, and isolated p53 KD PSA-NCAM+ cells show a 
metabolic gene imbalance towards decreased OXPHOS. In summary, we 
hypothesized that in humans, p53 regulates neurogenesis, possibly through 
regulating energy pathways.  
 
3.3 MANUSCRIPT – GENERATION OF A 2D AND A 3D SYSTEM TO 
UNDERSTAND NEUROPSYCHIATRIC DISORDERS 
In this manuscript we sought to combine the best aspects from both paper I and 
paper II and apply it to neuropsychiatric disorders.  
We show that the generated stem cell layer in the organoids resemble that of a 
mouse brain. The generated TBR1+ cortical layer is clearly separated from the stem 
cell layer and some RELN+ cells made their way to the upper layers of the cortex. 
Further on in differentiation, GLAST+ radial glia appear together with sporadic 
GFAP+ fibers. Which glial population these fibers represent needs to be 
determined. The presence of GFAP in the developing brain can be attributed to 
either astrocytes or radial glia, with the delta isoform of GFAP (GFAP∆) lines 
specifically the human ventricular zone 27. This specificity is not appreciated in the 
mouse brain, where GFAP∆ is more widely spread between astrocytes, neurogenic, 
and non-neurogenic stem cells 28. We further show the ability to generate 
organoids from an ASD patient and SZ patient. These organoids show hints of 
developing the oSVZ layer with HOPX+ oRG cells. oRG cells are thought to be a 
major contributing factor to the expansion of the human neocortex 40, and 
therefore of vital importance to model human brain development. 
 
Part of what makes us human, is how information is processed. In the brain that is 
done via neurons and their action potentials. Interestingly, when comparing 
macaque to human neurons in the amygdala and the cingulate cortex, the human 
neurons were more efficient with a higher information capacity (spikes are more 
efficiently distributed) 204. The authors postulate a correlation between the tradeoff 
seen with a higher efficiency and lower robustness to a possible propensity of 
human psychopathologies. In the developing human cortical plate, some neurons 
that are capable of firing a single provoked action potential (AP) are present as 
early as 16 weeks into the gestational period, but repeated APs were not present 
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before week 20 205. This falls relatively well in the timeframe described of recordings 
from organoids where no spontaneous APs were detected after four months of 
differentiation (~16 weeks), but ample activity was visible after eight months (~32 
weeks) 176. Further comparison of organoids development to network activity from 
neonatal fetuses showed remarkable similarities 206. As the authors state, there are 
many factors to take into consideration. Interreference of the skull, 
electroencephalogram (EEG) acquisition and electrode placement are all 
cofounding factors. Similar to in vivo recordings, the in vitro data is variable. 
Starting from single cells could yield slight population differences in early stages 
that will have profound effects later on the differentiation. In addition, placement 
on the Multi Electrode Array (MEA) and organoid manipulation are confounding 
factors to signal acquisition. Taking this into account, the observed similarities are 
striking. There is significant correlation of organoids from 25 weeks and on to the 
developing human brains’ network formation. Over the course of differentiation 
both burst frequency and synchronization kept on climbing from two to the tenth 
months. While these correlations were not observed in mouse derived primary cells 
and 2D monolayer iPSCs.  
 
Since the emergence of electrical activity has a relative long timescale, we explored 
an alternate way to assess neural network dynamics. Calcium network dynamics 
have been used previously to assess functionality and maturity of neural networks 
142,207,208. Our subset isolation confirmed the increased cell specificity obtained after 
magnetic activated cell separation (MACS), and allowed for plating and subsequent 
calcium dynamic analysis. This showed a gradual maturation over time as indicated 
by the shorter spike intervals and increased amplitude of the transients, as 
observed previously in maturing cultured neurons 209. Therefore, we show that the 
approach of determining maturation and network formation from an isolated neural 
population works, and is in line with previous findings. However as discussed 
previously, 2D neural networks have a relatively poor correlation with the 
developing human brain 206. Therefore, in depth studies might be better suited to 
be tested in an organoid like system. However, because ease of use and 
inexpensive costs, initial drug screening for effectiveness or toxicity would be still 
a suitable application for 2D derived neural systems.   
 
To combine the usability of a 2D system with the apparent in vivo similarities of the 
organoids we analyzed the survival and differentiation of transplanted NES cells in 
neuroectodermal like structures. GFP expressing NES cells were injected into the 
organoid and allowed to differentiate for 30 days. Not only did the cells survive the 
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transplantation, they also differentiated to some extent. As previously 
demonstrated, NES cells mainly form GABAergic neurons upon differentiation 140. 
This is also apparent in our transplanted cells. Large GFP+ clusters surrounding 
GABA+ cells were apparent, with possible some FOXG1+ cells intermingled. If 
confirmed to be true, it would indicate some degree of intrinsic flexibility in stem 
cell fate or retained heterogeneity in the stem cell population. It has recently been 
shown that NES cells are heterogeneous to some degree, and that in the stem cell 
state populations with the potential of generating excitatory, inhibitory, and 
gliogenic cells exist 210.  
With this work we show the usability and feasibility of organoids as a model system, 
as well as some limitations that can be taken into consideration to study 
neurodevelopmental disorders. 
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4 CONCLUSION AND FUTURE PERSPECTIVES 
Gaining greater understanding in pathways involved in human neurogenesis is 
essential to understand the workings of our brain. But what the functional 
outcomes are is equally important however, often much more difficult to obtain. 
Our example, human brain development, is for obvious reasons difficult to study in 
humans. Obtaining human material is often variable and cumbersome therefore we 
aim to increase the understanding and usability of in vitro systems. The focus on in 
vitro does come with considerations and the different aspects of a simpler, more 
homogenic 2D neural stem cell system all the way to whole brain organoids that 
offer a wider variety of cell types and interactions (Figure 6). 
 
 
Figure 6: The Trade-Off between Homogeneity and Complexity. Keleva and Lancaster 2016  
(A) A scale showing the relationship of the complexity of the cells/tissue produced by individual 
protocols and the homogeneity of the cells/tissues generated. For individual methods, please see 
main text. The individual cells/tissues are not shown to scale. The color scheme does not represent 
the exact number of cell types. (B) Cartoons depicting individual regions of cortical tissue from 
various methods demonstrating their relative sizes. Traces were performed on actual images from 
the following studies in left to right order: Neural rosettes: Figure 3d-i from Chambers et al. (2009) 
and Figure 1d from Kirwan et al. (2015); SFEBq: Figure 6N of Eiraku et al. (2008); cortical spheroids: 
Figure 2a from Pasxca et al. (2015); forebrain organoids: Figure 3A from Kadoshima et al. (2013); 
cerebral organoids: Figure 4 from Karus et al. (2014) (this is an image of a cerebral organoid cultured 
as in the original Lancaster et al., 2013). Images chosen for the tracing were at similar stages of 
development based on timing and thickness of the VZ compared to outer regions. For those with 
multiple matched images, the largest was used for tracing. All images are scaled to one another; 
scale bar in all images represents 100 mm. Reproduced with permission from the publisher.  
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With the realization that more and more aspects of the human brain are unique to 
homo sapiens such as progenitor cell specific NOTCH signaling in cortical 
development 211, or the duplication of a gene, that resulted in ARHGAP11B, that 
when introduced in the mouse possibly promotes gyrification 118, one of the 
defining factors for the increased cortical area seen in humans. Notably, the 
localization of this human specific protein has recently been shown to be in the 
mitochondria of basal progenitor cells, where it promotes proliferation trough 
glutaminolysis 117.  
 
Further work also needs to focus on astrocytes, since they might outnumber 
neurons in the brain 212, but are distinctly more complex and on average 2,6 times 
larger with ten times more processes than their mouse counterparts 120,121. 
Interestingly, this realization has created a new niche of investigation, namely 
human glial chimeric mice. Although it is not a new notion to generate chimeric 
rodents with the transplantation of human precursor cells 213, the realization of the 
complexity of the human brain has made researches searching for increased human 
likeness in their models. Mice transplanted with glial precursor cells showed an 
increased enhanced learning ability and plasticity of the host 119, and are continuing 
to show their involvement in neuropsychiatric disorders such as schizophrenia 214. 
Therefore, integrating human cells in research would be a step to consider to 
improve translation to patients.  
 
Lessons from the previous two papers and manuscript brought this thesis to its 
purpose. The question lies before us on what would be a suitable approach to study 
neurodevelopmental disorders. What we have generated here, attempts to tie 
together form and function. Form, in the way that histologically, brain development 
is recapitulated. Development of the different cell types that make up the brain 
and their proper placement, is of course, the cornerstone of any developmental 
project. As we have seen in paper I, migration defects and, neurite projection are 
major phenotypes in lissencephaly that we could recapitulate in vitro. The model 
system did however lack ability to mimic the organizational structure found in the 
brain, as is true for many 2D neuronal systems. It did allow for the recapitulation of 
known in vivo phenotypes such as migration defects 
 
At the start of my PhD I remember distinctly saying that I do not want to work on 
cancer, and here I am, coming dangerously close. It is true that any given protein 
on its own does not equal cancer, but as far as cancer associated proteins go, p53 
is at the top of the list. Not surprisingly though, it is the most altered gene in human 
   29 
 
 
cancers 215. Depending on who you ask, it is either the most important gene in life 
or, “it is that gene that the cancer people play with”. However, Paper II, made me 
realize the similarities. On a basal level, the glycolytic phenotypes in cancer and the 
seemingly similar profile of neural stem cells in which p53 is knocked down made 
way for the field of (cancer) metabolism to guide us in understanding the 
phenotypes seen in our 2D and 3D cell models. This paper was challenging and 
interesting in many ways. Most intriguing the seemingly conflicting results of 
enhanced or accelerated neural differentiation from our NES cells, and the 
observed impairment of neurogenesis in our 3D organoids. I think it is important 
to mention this, and without trying both systems side by side we possibly would 
not have seen both phenotypes. Comparing these systems is of course unfair in 
many ways. The NES cells had a “normal”, albeit 2D development towards 
neuroectoderm before KD of p53, whereas the organoids dealt with KD of p53 
from the iPSC stage. Opening up the possibility to altered mechanisms during 
initial differentiation towards neuroectodermal fate. 
 
Learning from paper I and paper II, in the Manuscript we sought to combine the 
strengths from both 2D and 3D cultures, and applied them to neuropsychiatric 
disorders. Here the greatest challenge was to find ways to combine functionality 
assays to cell culture that could resemble human brain function. Fortunately, there 
are lessons to learn from the mouse and the study of its brain. Since the focus was 
neuropsychiatric disorders, we aimed for neuronal functionality, the most common 
drug target. Interestingly, when researchers compared preterm EEG with 
organoids, 2D control iPSCs, fetal cells and mouse primary culture, the correlation 
of 2D and mouse cells was actually negative. Meanwhile, in ascending order of 
Pearson correlation, 2D fetal cells (0,1), organoids (<25 weeks, 0,4), organoids (>25 
weeks, 0,6), and lastly, held out neonatal recordings (0,75) showed significant 
similarities with the developing brain 206. This together with several reports on the 
transcriptomic similarities of organoids to human brain development 
153,154,176,201,202,206,216,217, does make a strong stand on the usability and resemblance 
of brain organoids to fetal brains. However recently a possible cell culture effect 
has been explored on 3D cell culture. When organoids and isolated fetal brain 
tissue was grown in cell culture researchers saw markers of endoplasmatic reticulum 
stress upregulated 218,219. And not only in tissue, in their starting iPSCs these markers 
were present. Interestingly, when cells from the organoid were transplanted to the 
mouse brain, these markers seemed to be downregulated again.  
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Together the work in this thesis shows that in vitro cell culture can be a relative 
good model to address pathologies that animal models lack. However, like all 
models, we need to take into consideration the limitations of in vitro systems like 
2D neural stem cells or 3D organoids. The lack of cell types able to interact with 
each other, nutrient flow, and mitogens from different parts of the body are just a 
few examples of factors we have yet to control in vitro. Therefore, I would like to 
close this thesis with my opening statement:  
 
 
“Essentially, all models are wrong, but some are useful” 
George E.P. Box   
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